Adam Silverman, DPM
Foot & Ankle Surgery · Baltimore, MDNPI 1184760563
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,000 of the $8,522 with a category attached, or 70.4%. Aroa Biosurgery Incorporated accounts for 84.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2020 at $7,343 and has fallen 99.6% since, to $31 in 2025.
Across 51 payments — averaging $167.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$7K
- Smith+Nephew$432
- Nevro Corp.$153
- Organogenesis Inc.$131
- Triad Life Sciences Inc.$112
- Kerecis Limited$75
- plus $383 from 14 others
What the payments were for
- Consulting fees$1,20014%
- Speaking & faculty fees$6,00070%
- Travel & lodging$160%
- Food & beverage$1,29515%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 6 | $7,236 |
| Smith+Nephew | 16 | $432 |
| Nevro Corp. | 2 | $153 |
| Organogenesis Inc. | 3 | $131 |
| Triad Life Sciences Inc. | 1 | $112 |
| Kerecis Limited | 2 | $75 |
| Integra Lifesciences Corporation | 3 | $59 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $40 |
| Hydrofera LLC | 2 | $37 |
| Hollister Incorporated | 1 | $25 |
| Polarityte, Inc. | 1 | $25 |
| Medline Industries LP | 1 | $22 |
| Misonix Inc | 1 | $22 |
| AbbVie | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Hartmann USA, Inc. | 1 | $18 |
| OVIK Health, LLC | 1 | $16 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Normatec Industries, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$128
- GRAFIX PL$126
- Oasis$126
- STRAVIX PL$126
- InnovaMatrix AC$112
How this compares
$8,522 in reported general payments places this provider in the 75th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 39 | $12,535 |
| Gentamicin Sulfate | 50 | $1,112 |
| Doxycycline Hyclate | 25 | $746 |
| Ciprofloxacin Hcl | 31 | $737 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $678 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $508 |
| Clindamycin Hcl | 13 | $158 |
| Meloxicam | 13 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $432 | $12,53539 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 182 foot & ankle surgery providers in Maryland.
Other foot & ankle surgery in Baltimore
- Lew SchonBaltimore$752K
- Stuart MillerBaltimore$583K
- Patrick MaloneyBaltimore$262K
- Gregory GuytonBaltimore$216K
- Clifford JengBaltimore$74K
- Kyung SeoBaltimore$23K
- Richard SmithBaltimore$18K
- Jacob WisbeckBaltimore$17K
- Stephen JacobsenBaltimore$17K
- Brady WilliamsBaltimore$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.